Domenico Accili
Affiliations: | Columbia University, New York, NY |
Area:
Biomedical EngineeringWebsite:
https://www.gsas.cuimc.columbia.edu/profile/domenico-accili-mdGoogle:
"Domenico Accili"Children
Sign in to add trainee| Haruka Okamoto | grad student | 2005 | Columbia |
| Chutima Talchai | grad student | 2010 | Columbia |
| Joshua R. Cook | grad student | 2014 | Columbia |
| Y. Rachel Kim | grad student | 2011-2016 | Columbia (Neurotree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Khan S, Gaivin RJ, Liu Z, et al. (2025) Fatty Acid Transport Protein-2 (FATP2) Inhibition Enhances Glucose Tolerance through α-Cell-mediated GLP-1 Secretion. Biorxiv : the Preprint Server For Biology |
| Accili D, Talchai SC, Bouchi R, et al. (2024) Diabetes treatment by conversion of gut epithelial cells to insulin-producing cells. Journal of Diabetes Investigation |
| Watanabe H, Asahara SI, Son J, et al. (2024) Cyb5r3 activation rescues secondary failure to sulfonylurea but not β-cell dedifferentiation. Plos One. 19: e0297555 |
| Suda N, Bartolomé A, Liang J, et al. (2024) β-cell Jagged1 is sufficient but not necessary for islet Notch activity and insulin secretory defects in obese mice. Molecular Metabolism. 81: 101894 |
| Pajvani UB, Shawber CJ, Samuel VT, et al. (2023) Author Correction: Inhibition of Notch signaling ameliorates insulin resistance in a FoxO1-dependent manner. Nature Medicine |
| Park J, Hall C, Hubbard B, et al. (2023) MAD2-dependent insulin receptor endocytosis regulates metabolic homeostasis. Diabetes |
| Son J, Accili D. (2023) Reversing pancreatic β-cell dedifferentiation in the treatment of type 2 diabetes. Experimental & Molecular Medicine. 55: 1652-1658 |
| Kitamoto T, Accili D. (2023) Unraveling the mysteries of hepatic insulin signaling: deconvoluting the nuclear targets of insulin. Endocrine Journal |
| Son J, Du W, Esposito M, et al. (2023) Genetic and pharmacologic inhibition of ALDH1A3 as a treatment of β-cell failure. Nature Communications. 14: 558 |
| Watanabe H, Du W, Son J, et al. (2023) Cyb5r3-based mechanism and reversal of secondary failure to sulfonylurea in diabetes. Science Translational Medicine. 15: eabq4126 |